REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $955,449 | -51.6% | 83,300 | +6.9% | 0.00% | -100.0% |
| Q2 2023 | $1,972,104 | +44.5% | 77,918 | +83.9% | 0.00% | – |
| Q1 2023 | $1,364,963 | +112.8% | 42,377 | +22.0% | 0.00% | – |
| Q4 2022 | $641,337 | -28.0% | 34,742 | +5.2% | 0.00% | – |
| Q3 2022 | $891,000 | +55.0% | 33,025 | -20.6% | 0.00% | – |
| Q2 2022 | $575,000 | -29.6% | 41,619 | -0.7% | 0.00% | – |
| Q1 2022 | $817,000 | +21.0% | 41,900 | +1.3% | 0.00% | – |
| Q4 2021 | $675,000 | -24.7% | 41,362 | +28.6% | 0.00% | – |
| Q3 2021 | $896,000 | +60.0% | 32,175 | +70.4% | 0.00% | – |
| Q2 2021 | $560,000 | +9.8% | 18,879 | +3.4% | 0.00% | – |
| Q1 2021 | $510,000 | +5.4% | 18,254 | +6.8% | 0.00% | – |
| Q4 2020 | $484,000 | +6.4% | 17,090 | -5.5% | 0.00% | – |
| Q3 2020 | $455,000 | -6.2% | 18,094 | -8.9% | 0.00% | – |
| Q2 2020 | $485,000 | +71.4% | 19,871 | +4.2% | 0.00% | – |
| Q1 2020 | $283,000 | -5.0% | 19,064 | +4.0% | 0.00% | – |
| Q4 2019 | $298,000 | +129.2% | 18,326 | +82.7% | 0.00% | – |
| Q3 2019 | $130,000 | +16.1% | 10,032 | +16.4% | 0.00% | – |
| Q2 2019 | $112,000 | -6.7% | 8,621 | +13.2% | 0.00% | – |
| Q1 2019 | $120,000 | -7.7% | 7,613 | +18.1% | 0.00% | – |
| Q4 2018 | $130,000 | -0.8% | 6,445 | +21.7% | 0.00% | – |
| Q3 2018 | $131,000 | -9.7% | 5,295 | 0.0% | 0.00% | – |
| Q2 2018 | $145,000 | -8.8% | 5,295 | +2.5% | 0.00% | – |
| Q1 2018 | $159,000 | -23.9% | 5,168 | -11.0% | 0.00% | – |
| Q4 2017 | $209,000 | +31.4% | 5,806 | 0.0% | 0.00% | – |
| Q3 2017 | $159,000 | +4.6% | 5,806 | -0.2% | 0.00% | – |
| Q2 2017 | $152,000 | +38.2% | 5,815 | +8.1% | 0.00% | – |
| Q1 2017 | $110,000 | -2.7% | 5,377 | -1.1% | 0.00% | – |
| Q4 2016 | $113,000 | +94.8% | 5,437 | +52.7% | 0.00% | – |
| Q3 2016 | $58,000 | +18.4% | 3,561 | 0.0% | 0.00% | – |
| Q2 2016 | $49,000 | -22.2% | 3,561 | 0.0% | 0.00% | – |
| Q1 2016 | $63,000 | -30.8% | 3,561 | +39.0% | 0.00% | – |
| Q4 2015 | $91,000 | +24.7% | 2,561 | 0.0% | 0.00% | – |
| Q3 2015 | $73,000 | +25.9% | 2,561 | +43.2% | 0.00% | – |
| Q2 2015 | $58,000 | +205.3% | 1,788 | +87.6% | 0.00% | – |
| Q1 2015 | $19,000 | +18.8% | 953 | 0.0% | 0.00% | – |
| Q4 2014 | $16,000 | -15.8% | 953 | 0.0% | 0.00% | – |
| Q3 2014 | $19,000 | – | 953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |